Discussion about this post

User's avatar
Jeffrey William's avatar

The insurance companies aren't the only problem. Private equity investment and large provider organizations that hoover up small independent practices contribute to price increases and lack of competition. The market is utterly distorted by government regulation, insurance companies, and outfits like the Cleveland Clinic. There's little hope for relief in the USA simply because of the massive amount of monied interests involved in the "industry".

Where we have experienced health care that works is in places where health care is viewed as a public service and not as a profit center for insurance companies or private equity peeps. South Korea has an amazing system. Until recently all hospitals were required to be operated as non-profits. This is NOT social medicine. While health care providers are all private, the government runs the funding scheme. Everyone is required to pay into the system (about $100 per month) and at time of treatment there are small co-pays or additional fees. A two view X-ray at a major hospital cost us $21. Cleveland Clinic quoted us $950 for the _same thing_. Hospitals have to compete for patients since they are paid on a per patient service basis and not a flat rate over time. So hospitals in Korea have become very efficient at serving patients. A wait to see a provider in a hospital of more than 3 or 4 days is unusual. Small clinics see patients on a walk-in basis, same day service. Try THAT in the USA.

Here in Taiwan the system is similar to Korea's. Our monthly payment is about $58. Oh, and this covers vision and dental as well. Prescriptions are reasonable. One that costs us $75 in the USA only costs $8 here. The co-pay for my weekly shoulder therapy visit?: $1.75.

I fear that the whole system in the USA will have to come crashing down disastrously before anything can be done to improve the situation. There are just too many deeply entrenched well-heeled interests with political connections to permit any sort of meaningful change to take place.

TheRanter's avatar

The 59% number on vertical integration is significant, but what's more striking is that voters are identifying the mechanism without having the vocabulary for it. When one company owns the insurer, the PBM, the data analytics platform, and employs the doctors, the "competition" that's supposed to constrain prices doesn't exist. Voters feel that. This data confirms they can name it.

The PBM steering finding is worth highlighting. Prohibiting PBMs from profiting when patients are steered toward higher-priced drugs polls at 37% top priority, but the underlying structure is worse than most voters realize. The three largest PBMs control roughly 80% of the market and are owned by the three largest insurers. The entity deciding which drug you get and the entity profiting from that decision are the same company. That's not a market failure. That's the market working exactly as structured.

Interested to see whether future surveys break out voter awareness of specific integration patterns. The polling shows people know something is wrong. The policy question is whether they can connect "my prescription costs too much" to "my insurer owns my pharmacy benefit manager."

No posts

Ready for more?